LBA announces new £455k HMRC Approved EIS Roundtable Syndicate Fund with total raised to date by LBA Funds at circa £1.2m since 2010
LBA is delighted to announce that the new £455k HMRC Approved EIS Roundtable Syndicate Fund is open for business in FY 2012/13 with all cash now held by the Fund’s Registrars. This Fund, being the biggest raised by LBA to date, will seek to act as a catalyst for investment through co-investment in circa 5-6 LBA companies in FY 2012/13 alongside LBA investors. Notably, the Fund is also a syndicate partner of the £50m government backed angel co-fund (http://www.angelcofund.co.uk/) giving the fund a potential investment partner in relation to all qualifying deals.
LBA’s first £300k LBA EIS Roundtable Syndicate Fund was fully invested in January 2011, making four investments as part of LBA syndicates in leading edge technologies during the previous year, spread across a range of sectors: Eykona (Medtech), Syrinix (Cleantech), Ipadio (Mobile), The Electrospinning Company (Nanotech).LBA’s second £420k fund was fully invested in April 2012, making investments into 5 companies as part of LBA syndicates in leading edge technologies during the previous year, spread across a range of sectors as below: Camstent (Medtech), Momentum Bioscience (Medtech), Phase Vision (High Value Manufacturing), Michelson Diagnostics (Medtech), Isotera (Cleantech)
Anthony Clarke, Managing Director of LBA comments, “Our latest LBA EIS Roundtable Fund offers companies which build angel syndicates, an opportunity to significantly increase the level of investment achieved through the LBA network. We are particularly pleased that LBA and this Fund is now a syndicate partner of the Angel Cofund which gives the LBA network further investment firepower. The LBA EIS Roundtable Syndicate Fund model has now raised £1.175m since 2010 and continues to offer LBA members a portfolio approach to angel investing thereby increasing the chances of achieving sustainable returns.”
Companies: For the opportunity to present your business to our investors and potentially leverage LBA's Fund, please click here to find out more about the service we provide before making an application to companies@lbangels.co.uk.
Investors: For more information about the service LBA provides for investors and how to get involved in the Fund's next round please click here.
London Business Angels
Anthony Clarke, Managing Director
Tel: +44 (0)20 7321 5672
E-mail: enquiries@lbangels.co.uk
Web: www.lbangels.co.uk
About London Business Angels
LBA is one of the most experienced private angel networks in the UK. Since the early 1980s the network has been connecting innovating fast growth small and medium sized enterprises with investment through our network of business angel investors. LBA, part of Angel Capital Group, is professionally managed by a highly experienced management team, leveraging over 15 years’ experience in the early stage investment marketplace as established leaders in the development of new angel-led early stage investment initiatives, and nearly 30 years’ investing experience through the LBA network. LBA is a founding member of the British Business Angels Association, the industry's best practice trade association, and is also a member of EBAN, the European Business Angels Network.
About the LBA EIS/SEIS Approved RoundTable Syndicate Funds
The LBA EIS Approved RoundTable Syndicate Fund is the culmination of 30 years’ experience of pioneering innovation in the UK Angel investment market. This FSA regulated HMRC Approved EIS Fund offers LBA Investors an innovative way to acquire a portfolio of investments, while taking advantage of the personal tax relief offered by the Enterprise Investment Scheme. The First £300k LBA EIS RoundTable Fund 2010 was fully invested in January 2011, making four investments in leading edge technologies during the previous year, spread across a range of sectors: Eykona (medtech); Syrinix (cleantech); ipadio (mobile); The Electrospinning Company (nanotech).
Following the successful 2010 Fund, the LBA EIS Approved RoundTable Syndicate Fund 2011-12 closed for subscriptions on 13 May 2011, being 40% larger at £420k. The fund invested in 5 leading edge technologies spread across a range of sectors: Camstent (medtech), Momentum Bioscience (medtech), Phase Vision (high value manufacturing), Michelson Diagnostics (medtech), Isotera (cleantech)
The LBA EIS Roundtable Syndicate Fund 2012, closed for subsciprtions on 5th April 2012, being the largest raised to date at £455k. The fund will seek to invest in 5-6 early stage companies in the forthcoming year.
The LBA SEIS Roundtable Syndicate Fund 2012, closed for subscriptions on 19th October 2012 and will seek to co-invest across 4-5 SEIS eligible deals alongside LBA investors
